Inhibition of Mitogen-Activated Kinase Signaling Sensitizes HeLa Cells to Fas Receptor-Mediated Apoptosis

REFERENCES

• Aggarwal, B. B., S. Singh, R. LaPushin, and J. Totpal 1995. Fas antigen signals proliferation of normal human diploid fibroblast and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364:5–12.
   PubMed Web of Science ®Google Scholar
• Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and J. Saltiel 1995. PD 098059 is a specific inhibitor of the mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 46:27489–27494.
   Google Scholar
• Baron, U., S. Freundlieb, and J. Bujard 1995. Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res. 23:3605–3606.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., and J. Baltimore 1995. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782–784.
   Google Scholar
• Beidler, D. R., M. Tewari, P. D. Friesen, G. Poirier, and J. Dixit 1995. The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270:16526–16528.
   PubMed Web of Science ®Google Scholar
• Boldin, M. P., T. M. Goncharov, Y. V. Goltsev, and J. Wallach 1996. Involvement of MACH a novel MORT/Fadd-interacting protease in Fas/APO-1 and TNF receptor induced cell death. Cell 85:803–815.
   PubMed Web of Science ®Google Scholar
• Bursch, W., F. Oberhammer, and J. Schulte-Hermann 1992. Cell death by apoptosis and its protective role against disease. Trends Pharmacol. Sci. 13:243–251.
   Google Scholar
• Chinnaiyan, A. M., K. O’Rourke, M. Tewari, and J. Dixit 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505–512.
   PubMed Web of Science ®Google Scholar
• Cuvillier, O., G. Pirianov, B. Kleuser, P. G. Vanek, O. A. Coso, J. S. Gutkind, and J. Spiegel 1996. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800–803.
   PubMed Web of Science ®Google Scholar
• Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. M. Segal, D. R. Kaplan, and J. Greenberg 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661–665.
   PubMed Web of Science ®Google Scholar
• Evan, G. I., L. Brown, M. Whyte, and J. Harrington 1995. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 7:825–834.
   PubMed Web of Science ®Google Scholar
• Fisher, D. E. 1994. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539–542.
   PubMed Web of Science ®Google Scholar
• Franke, T. F., D. R. Kaplan, and J. Cantley 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435–437.
   PubMed Web of Science ®Google Scholar
• Freiberg, R. A., D. M. Spencer, K. A. Choate, H. J. Duh, S. L. Schreiber, G. R. Crabtree, and J. Khavari 1997. Fas signal transduction triggers either proliferation or apoptosis in human fibroblasts. J. Investig. Dermatol. 108:215–219.
   PubMed Web of Science ®Google Scholar
• Fried, J., A. G. Perez, and J. Clarkson 1978. Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures, some pitfalls in staining and data analysis. J. Histochem. Cytochem. 26:921–933.
   PubMedGoogle Scholar
• Gardner, A. M., and J. Johnson 1996. Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J. Biol. Chem. 271:14560–14566.
   PubMed Web of Science ®Google Scholar
• Gossen, M., and J. Bujard 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89:5547–5551.
   PubMed Web of Science ®Google Scholar
• Griswold-Prenner, I., C. R. Carlin, and J. Rosner 1993. Mitogen-activated protein kinase regulates the epidermal growth factor receptor through activation of a tyrosine kinase phosphatase. J. Biol. Chem. 268:13050–13054.
   PubMedGoogle Scholar
• Gulbins, E., R. Bissonnette, A. Mahboubi, S. Martin, W. Nishioka, T. Brunner, G. Baier, G. Baier-Bitterlich, C. Byrd, F. Lang, R. Kolesnick, A. Altman, and J. Green 1995. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2:341–351.
   PubMed Web of Science ®Google Scholar
• Gulbins, E., K. M. Coggeshall, B. Brenner, K. Schlottmann, O. Linderkamp, and J. Lang 1996. Fas-induced Apoptosis is Mediated by activation of a Ras and Rac protein-regulated signaling pathway. J. Biol. Chem. 271:26389–26394.
   PubMedGoogle Scholar
• Guo, Y.-L., B. Kang, and J. Williamson 1998. Inhibition of the expression of mitogen activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-α in rat mesengial cells. J. Biol. Chem. 273:10362–10366.
   PubMed Web of Science ®Google Scholar
• Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J. Cerottini, and J. Tschopp 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274:1363–1366.
   PubMed Web of Science ®Google Scholar
• Holmström, T. H., S. C. Chow, I. Elo, E. Coffey, S. Orrenius, L. Sistonen, and J. Eriksson 1998. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J. Immunol. 160:2626–2636.
   PubMed Web of Science ®Google Scholar
• Holt, K. H., B. G. Kasson, and J. Pessin 1996. Insulin stimulation of a MEK-dependent but ERK-independent SOS protein kinase. Mol. Cell. Biol. 16:577–586.
   PubMed Web of Science ®Google Scholar
• Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner, J.-L. Bodmer, M. Schröter, K. Burns, C. Mattmann, D. Rimoldi, L. E. French, and J. Tschopp 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190–194.
   PubMed Web of Science ®Google Scholar
• Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and J. Nagata 1991. The polypeptide encoded by the cDNA for human cell surface antigen can mediate apoptosis. Cell 66:233–243.
   PubMed Web of Science ®Google Scholar
• Itoh, N., and J. Nagata 1993. A novel protein domain required for apoptosis. J. Biol. Chem. 268:10932–10937.
   PubMed Web of Science ®Google Scholar
• Itoh, N., Y. Tsujimoto, and J. Nagata 1993. Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151:621–627.
   PubMed Web of Science ®Google Scholar
• Jelaska, A., and J. Korn 1998. Anti-Fas induces apoptosis and proliferation in human dermal fibroblasts: differences between foreskin and adult fibroblasts. J. Cell Physiol. 175:19–29.
   PubMed Web of Science ®Google Scholar
• Kaufmann-Zeh, A., P. Rodriquez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and J. Evan 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544–548.
   PubMedGoogle Scholar
• Kennedy, N. J., and J. Budd 1998. Phosphorylation of FADD/MORT1 and Fas by kinases that associate with the membrane-proximal cytoplasmic domain of Fas. J. Immunol. 160:4881–4888.
   PubMedGoogle Scholar
• Kischkel, F. C., S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P. H. Krammer, and J. Peter 1995. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14:5579–5588.
   PubMed Web of Science ®Google Scholar
• Khwaja, A., P. Rodriquez-Viciana, S. Wennström, P. H. Warne, and J. Downward 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:2783–2793.
   PubMed Web of Science ®Google Scholar
• Kulik, G., A. Klippel, and J. Weber 1997. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595–1606.
   PubMed Web of Science ®Google Scholar
• Lengyel, E., H. Wang, R. Gum, C. Simon, Y. Wang, and J. Boyd 1997. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively actived extracellular signal regulated kinase-1-dependent signaling cascade. Oncogene 29:2563–2573.
   Google Scholar
• Lewis, T. S., P. S. Shapiro, and J. Ahn 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74:49–139.
   PubMed Web of Science ®Google Scholar
• Liston, P., N. Roy, K. Tamai, C. Lefebvre, S. Baird, G. Horvat, R. Farahani, M. McLean, J. E. Ikeda, A. McKenzie, and J. Korneluk 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379:349–353.
   PubMed Web of Science ®Google Scholar
• Malinin, N. L., M. P. Boldin, A. V. Kovalenko, and J. Wallach 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385:540–544.
   PubMed Web of Science ®Google Scholar
• Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and J. Ahn 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Nature 265:966–970.
   Google Scholar
• Mansour, S. J., J. M. Candia, J. E. Matsuura, M. C. Manning, and J. Ahn 1996. Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1. Biochem. 35:15529–15536.
   PubMedGoogle Scholar
• Marte, B. M., and J. Downward 1997. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22:355–358.
   PubMed Web of Science ®Google Scholar
• Martins, L. M., and J. Earnshaw 1997. Apoptosis: live and kicking in 1997. Trends Cell Biol. 7:111–114.
   PubMed Web of Science ®Google Scholar
• McKillop, I. H., C. M. Schmidt, P. A. Cahill, and J. Sitzmann 1997. Altered expression of mitogen-activated protein kinases in a rat model of experimental hepatocellular carcinoma. Hepatology 6:1484–1491.
   Google Scholar
• Medema, J. P., C. Scaffidi, F. C. Kischkel, A. Shevchenko, M. Mann, P. H. Krammer, and J. Peter 1997. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16:2794–804.
   PubMed Web of Science ®Google Scholar
• Mori, S., K. Murakami-Mori, A. Jewett, S. Nakamura, and J. Bonavida 1996. Resistance of AIDS-associated Kaposi’s sarcoma cells to Fas-mediated apoptosis. Cancer Res. 56:1874–1879.
   PubMedGoogle Scholar
• Morimoto, H., S. Yonehara, and J. Bonavida 1993. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res. 53:2591–2596.
   PubMedGoogle Scholar
• Morrison, P., A. R. Saltiel, and J. Rosner 1996. Role of mitogen-activated protein kinase kinase in regulation of the epidermal growth factor receptor by protein kinase C. J. Biol. Chem. 271:12891–12896.
   PubMedGoogle Scholar
• Nagata, S., and J. Golstein 1995. The Fas death factor. Science 267:1449–1456.
   PubMed Web of Science ®Google Scholar
• Nicoletti, I., G. Migliorati, C. Pagliacci, F. Grignani, and J. Riccardi 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 13:271–279.
   Google Scholar
• Nophar, Y., H. Holtmann, R. Ber, and J. Wallach 1988. Dominance of resistance to the cytocidal effect of tumor necrosis factor in heterokaryons formed by fusion of resistant and sensitive cells. J. Immunol. 140:3456–3460.
   PubMed Web of Science ®Google Scholar
• Northwood, I. C., F. A. Gonzalez, F. A. Wartmann, D. L. Raden, and J. Davis 1991. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 266:15266–15276.
   PubMed Web of Science ®Google Scholar
• O’Connell, J., G. C. O’Sullivan, J. K. Collins, and J. Shanahan 1996. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184:1075–1082.
   PubMed Web of Science ®Google Scholar
• Peter, M. E., F. C. Kischkel, S. Hellbardt, A. M. Chinnaiyan, P. H. Krammer, and J. Dixit 1996. CD95 (APO-1/Fas)-associating signalling proteins. Cell Death Differ. 3:161–165.
   PubMedGoogle Scholar
• Rothe, M., M. G. Pan, W. J. Henzel, T. M. Ayres, and J. Goeddel 1995. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83:1243–1252.
   PubMed Web of Science ®Google Scholar
• Sato, T., S. Irie, S. Kitada, and J. Reed 1995. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411–415.
   PubMed Web of Science ®Google Scholar
• Scaffidi, C., S. Fulda, A. Srinivasan, C. Friesen, F. Li, K. J. Tomaselli, K.-M. Debatin, P. H. Krammer, and J. Peter 1998. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1675–1687.
   PubMed Web of Science ®Google Scholar
• Schlegel, J., I. Peters, S. Orrenius, D. K. Miller, N. A. Thornberry, T.-T. Yamin, and J. Nicholson 1996. CPP32/Apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 4:1841–1844.
   Google Scholar
• Seino, K.-I., N. Kayagaki, K. Okumura, and J. Yagita 1997. Antitumor effect of locally produced CD95 ligand. Nat. Med. 3:165–170.
   PubMed Web of Science ®Google Scholar
• Shievella, A. R., J. H. Chen, J. R. Graham, and J. Lin 1997. MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 272:12069–12075.
   PubMedGoogle Scholar
• Smith, C. A., T. Farrah, and J. Goodwin 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76:959–962.
   PubMed Web of Science ®Google Scholar
• Sorenson, C. M., M. A. Barry, and J. Eastman 1990. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J. Natl. Cancer Inst. 8:749–755.
   Google Scholar
• Strand, S., W. J. Hofmann, H. Hug, M. Muller, G. Otto, D. Strand, S. M. Mariani, W. Stremmel, and J. Krammer 1996. Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand expressing tumor cells—a mechanism of immune evasion? Nat. Med. 2:1361–1366.
   PubMed Web of Science ®Google Scholar
• Tewari, M., and J. Dixit 1995. Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270:3255–3260.
   PubMed Web of Science ®Google Scholar
• Thome, M., P. Schneider, K. Hofmann, H. Fickenscher, E. Meini, F. Neipel, C. Mattmann, K. Burns, J.-L. Bodmer, M. Schröter, C. Scaffidi, P. H. Krammer, M. E. Peter, and J. Tschopp 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517–521.
   PubMed Web of Science ®Google Scholar
• Tian, Q., J.-L. Taupin, S. Elledge, M. Robertson, and J. Anderson 1995. Fas-activated serine/threonine kinase phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182:865–874.
   PubMedGoogle Scholar
• Toyoshima, F., T. Moriguchi, and J. Nishida 1997. Fas induces cytoplasmic apoptotic responses and activation of the MKK7-JNK/SAPK and MKK6-p38 pathways independent of CPP32-like proteases. J. Cell Biol. 139:1005–1015.
   PubMed Web of Science ®Google Scholar
• Tran, S. E. F., T. H. Holmström, V. L. Johnson, M. Ahonen, S. C. Chow, V.-M. Kähäri, and J. E. Eriksson. Unpublished observations.
   Google Scholar
• Ungefroren, H., M. Voss, M. Jansen, C. Roeder, D. Henne-Bruns, B. Kremer, and J. Kalthoff 1998. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res. 15:1741–1749.
   Google Scholar
• Wallach, D. 1997. Cell death induction by TNF: a matter of self control. Trends Biochem. Sci. 22:107–109.
   PubMed Web of Science ®Google Scholar
• Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and J. Verma 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787–789.
   PubMed Web of Science ®Google Scholar
• Wang, C.-Y., M. W. Mayo, A. S. Baldwin Jr.. 1996. TNF- and cancer-therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784–787.
   PubMed Web of Science ®Google Scholar
• Waskiewicz, A. J., and J. Cooper 1995. Mitogen and stress response pathway: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr. Opin. Cell Biol. 7:7981–7989.
   Google Scholar
• Williams, G. T. 1991. Programmed cell death: apoptosis or oncogenesis. Cell 65:1097–1098.
   PubMed Web of Science ®Google Scholar
• Williams, R., J. Sanghera, F. Wu, D. Carbonaro-Hall, D. L. Campbell, D. Warburton, S. Pelech, and J. Hall 1993. Identification of a human epidermal growth factor receptor-associated protein kinase as a new member of the mitogen-activated protein kinase/extracellular signal-regulated protein kinase family. J. Biol. Chem. 268:18213–18217.
   PubMedGoogle Scholar
• Wright, S. C., J. Zhong, and J. Larrick 1994. Inhibition of apoptosis as a mechanism of tumor promotion. FASEB J. 8:654–660.
   PubMed Web of Science ®Google Scholar
• Wyllie, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555–556.
   PubMed Web of Science ®Google Scholar
• Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and J. Greenberg 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331.
   PubMed Web of Science ®Google Scholar
• Yang, X., R. Khosravi-Far, H. Y. Chang, and J. Baltimore 1997. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89:1067–1076.
   PubMed Web of Science ®Google Scholar
• Yonehara, S., A. Ishii, and J. Yonehara 1989. A cell-killing monoclonal antibody (Anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747–1756.
   PubMed Web of Science ®Google Scholar
• Zhang, J., and J. Winoto 1996. A mouse Fas-associated protein with homology to the Mort1/FADD protein is essential for Fas-induced apoptosis. Mol. Cell. Biol. 16:2756–2763.
   PubMed Web of Science ®Google Scholar